The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 22 06 2020
accepted: 03 08 2020
pubmed: 13 9 2020
medline: 21 10 2020
entrez: 12 9 2020
Statut: ppublish

Résumé

COVID-19 outbreak has led to severe health burden in the elderly. Age, morbidity and dementia have been associated with adverse outcome. To evaluate the impact of COVID-19 on health status in home-dwelling patients. 848 home-dwelling outpatients with dementia contacted from April 27 to 30 and evaluated by a semi-structured interview to evaluate possible health complication due to COVID-19 from February 21 to April 30. Age, sex, education, clinical characteristics (including diagnosis of dementia) and flu vaccination history were obtained from previous medical records. Items regarding change in health status and outcome since the onset of the outbreak were collected. COVID-19 was diagnosed in patients who developed symptoms according to WHO criteria or tested positive at nasal/throat swab if hospitalized. Unplanned hospitalization, institutionalization and mortality were recorded. Patients were 79.7 years old (SD 7.1) and 63.1% were females. Ninety-five (11.2%) patients developed COVID-19-like symptoms. Non COVID-19 and COVID-19 patients differed for frequency of diabetes (18.5% vs. 37.9%, p < 0.001), COPD (7.3% vs. 18.9%, p < 0.001), and previous flu vaccination (56.7% vs. 37.9%, p < 0.001). Diabetes and COPD were positively associated with COVID-19, whereas higher dementia severity and flu vaccination showed an inverse association. Among COVID-19 patients, 42 (44.2%) were hospitalized while 32 (33.7%) died. Non COVID-19 patients' hospitalization and mortality rate were 1.9% and 1.2%, respectively. COVID-19 and COPD were significantly associated with the rate of mortality. A high proportion of adverse outcome related to COVID-19 was observed in home-dwelling elderly patients with dementia. Active monitoring though telehealth programs would be useful particularly for those at highest risk of developing COVID-19 and its adverse outcomes.

Sections du résumé

BACKGROUND BACKGROUND
COVID-19 outbreak has led to severe health burden in the elderly. Age, morbidity and dementia have been associated with adverse outcome.
AIMS OBJECTIVE
To evaluate the impact of COVID-19 on health status in home-dwelling patients.
METHODS METHODS
848 home-dwelling outpatients with dementia contacted from April 27 to 30 and evaluated by a semi-structured interview to evaluate possible health complication due to COVID-19 from February 21 to April 30. Age, sex, education, clinical characteristics (including diagnosis of dementia) and flu vaccination history were obtained from previous medical records. Items regarding change in health status and outcome since the onset of the outbreak were collected. COVID-19 was diagnosed in patients who developed symptoms according to WHO criteria or tested positive at nasal/throat swab if hospitalized. Unplanned hospitalization, institutionalization and mortality were recorded.
RESULTS RESULTS
Patients were 79.7 years old (SD 7.1) and 63.1% were females. Ninety-five (11.2%) patients developed COVID-19-like symptoms. Non COVID-19 and COVID-19 patients differed for frequency of diabetes (18.5% vs. 37.9%, p < 0.001), COPD (7.3% vs. 18.9%, p < 0.001), and previous flu vaccination (56.7% vs. 37.9%, p < 0.001). Diabetes and COPD were positively associated with COVID-19, whereas higher dementia severity and flu vaccination showed an inverse association. Among COVID-19 patients, 42 (44.2%) were hospitalized while 32 (33.7%) died. Non COVID-19 patients' hospitalization and mortality rate were 1.9% and 1.2%, respectively. COVID-19 and COPD were significantly associated with the rate of mortality.
DISCUSSION/CONCLUSIONS CONCLUSIONS
A high proportion of adverse outcome related to COVID-19 was observed in home-dwelling elderly patients with dementia. Active monitoring though telehealth programs would be useful particularly for those at highest risk of developing COVID-19 and its adverse outcomes.

Identifiants

pubmed: 32918696
doi: 10.1007/s40520-020-01676-z
pii: 10.1007/s40520-020-01676-z
pmc: PMC7486591
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2133-2140

Références

Fiorillo A, Gorwood P (2020) The consequences of the COVID-19 pandemic on mental health and implications for clinical practice. Eur Psychiatry 63:e32. https://doi.org/10.1192/j.eurpsy.2020.35
doi: 10.1192/j.eurpsy.2020.35 pubmed: 32234102 pmcid: 7156565
Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. https://doi.org/10.1001/jama.2020.4683
doi: 10.1001/jama.2020.4683 pubmed: 32203977
Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 180:934–943
doi: 10.1001/jamainternmed.2020.0994
Wang H, Li T, Barbarino P et al (2020) Dementia care during COVID-19. Lancet 395:1190–1191. https://doi.org/10.1016/S0140-6736(20)30755-8
doi: 10.1016/S0140-6736(20)30755-8 pubmed: 32240625 pmcid: 7146671
Naumova EN, Parisi SM, Castronovo D et al (2009) Pneumonia and influenza hospitalizations in elderly people with dementia. J Am Geriatr Soc 57:2192–2199. https://doi.org/10.1111/j.1532-5415.2009.02565.x
doi: 10.1111/j.1532-5415.2009.02565.x pubmed: 19874403
Hughes CP, Berg L, Danziger WL et al (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
doi: 10.1192/bjp.140.6.566
Folstein M, Folsten S, McHugh P (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189–198. https://doi.org/10.1016/0022-
doi: 10.1016/0022-
Katz S, Down TD, Cash HR et al (1970) Progress in the development of the index of ADL. Gerontologist 10:20–30
doi: 10.1093/geront/10.1_Part_1.20
WHO Coronavirus disease (2019) COVID-19 Situation Report – 43, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Grasselli G, Pesenti A, Cecconi M (2020) Critical care utilization for the COVID-19 outbreak and forecast during an emergency response. JAMA 323:1545. https://doi.org/10.1001/jama.2020.4031
doi: 10.1001/jama.2020.4031 pubmed: 32167538
Coronavirus disease 2019 (COVID-19): situation report-57. Published March 17, 2020. https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_2 . Accessed March 18, 2020
Livingston E, Bucher K (2020) Coronavirus disease 2019 (COVID-19) in Italy. JAMA 323:1335. https://doi.org/10.1001/jama.2020.4344
doi: 10.1001/jama.2020.4344 pubmed: 32181795
Michaela A. C. Vollmer, Swapnil Mishra, H Juliette T Unwin (2020) Report 20: Using mobility to estimate the transmission intensity of COVID-19 in Italy: a subnational analysis with future scenarios. Imperial College COVID-19 Response Team May 2020
Signorelli C, Scognamiglio T, Odone A (2020) COVID-19 in Italy: impact of containment measures and prevalence estimates of infection in the general population. Acta Biomed 1:175–179. https://doi.org/10.23750/abm.v91i3-s.951
doi: 10.23750/abm.v91i3-s.951
Norman DC (2016) Clinical features of infection in older adults. Clin Geriatr Med 32:433–441
doi: 10.1016/j.cger.2016.02.005
Wester AL, Dunlop O, Melby KK et al (2013) Age-related differences in symptoms, diagnosis and prognosis of bacteremia. BMC Infect Dis 13:346. https://doi.org/10.1186/1471-2334-13-346
doi: 10.1186/1471-2334-13-346 pubmed: 23883345 pmcid: 3733624
Metlay JP, Schulz R, Li Y et al (1997) Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 157:1453–1459. https://doi.org/10.1001/archinte.1997.00440340089009
doi: 10.1001/archinte.1997.00440340089009 pubmed: 9224224
Falsey AR, Baran A, Walsh EE (2015) Should clinical case definitions of influenza in hospitalized older adults include fever? Influenza Other Respir Viruses 9(Suppl 1):23–29
doi: 10.1111/irv.12316
Wang L, He W, Yu X et al (2020) Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 80:639–645. https://doi.org/10.1016/j.jinf.2020.03.019
doi: 10.1016/j.jinf.2020.03.019 pubmed: 32240670 pmcid: 7118526
Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 180:934–943. https://doi.org/10.1001/jamainternmed.2020.0994
doi: 10.1001/jamainternmed.2020.0994 pubmed: 32167524
Inciardi RM, Adamo M, Lupi L et al (2020) Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J 41:1821–1829. https://doi.org/10.1093/eurheartj/ehaa388
doi: 10.1093/eurheartj/ehaa388 pubmed: 32383763 pmcid: 7239204
Guan W, Ni Z, Hu Y (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032
doi: 10.1056/NEJMoa2002032
Schiffrin EL, Flack JM, Ito S et al (2020) Hypertension and COVID-19. Am J Hypertens 33:373–374. https://doi.org/10.1093/ajh/hpaa057
doi: 10.1093/ajh/hpaa057 pubmed: 32251498
Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https://doi.org/10.1016/s2213-2600(20)30116-8
doi: 10.1016/s2213-2600(20)30116-8 pubmed: 32171062 pmcid: 7118626
Zhang P, Zhu L, Cai J et al (2020) Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126:1671–1681
doi: 10.1161/CIRCRESAHA.120.317134
Meng J, Xiao G, Zhang J et al (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9:757–760. https://doi.org/10.1080/22221751.2020.1746200
doi: 10.1080/22221751.2020.1746200 pubmed: 32228222 pmcid: 7170368
Italy: individuals aged 65 years and older vaccinated against flu 1990–2018 Published by Statista Research Department, Jan 14, 2020
Marano G, Pariani E, Luconi E et al (2020) Elderly people: propensity to be vaccinated for seasonal influenza in Italy. Hum Vaccin Immunother. https://doi.org/10.1080/21645515.2019.1706931
doi: 10.1080/21645515.2019.1706931 pubmed: 32040352
Li Q, Tang B, Bragazzi NL et al (2020) Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability. Math Biosci 325:108378. https://doi.org/10.1016/j.mbs.2020.108378
doi: 10.1016/j.mbs.2020.108378 pubmed: 32507746 pmcid: 7229764
Salem ML, El-Hennawy D (2020) The possible beneficial adjuvant effect of influenza vaccine to minimize the severity of COVID-19. Med Hypotheses 140:109752. https://doi.org/10.1016/j.mehy.2020.109752
doi: 10.1016/j.mehy.2020.109752 pubmed: 32361099 pmcid: 7194943
Zeng Q, Langereis MA, van Vliet ALW et al (2008) Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci 105:9065–9069
doi: 10.1073/pnas.0800502105
Liotta G, Gilardi F, Scarcella P et al (2016) Trend and determinants of acute inpatient care for the elderly in Italy from 2001 to 2011. Annali di Igiene: Medicina Preventiva e di Comunita 28:319–327. https://doi.org/10.7416/ai.2016.2112
doi: 10.7416/ai.2016.2112
Czaja CA, Miller L, Alden N et al (2019) Age-related differences in hospitalization rates, clinical presentation, and outcomes among older adults hospitalized with influenza-U.S. influenza hospitalization surveillance network (FluSurv-NET). Open Forum Infect Dis 6:225. https://doi.org/10.1093/ofid/ofz225
doi: 10.1093/ofid/ofz225
Natale A, Ghio D, Tarchi D et al (2020) COVID-19 cases and case fatality rate by age. Knowledge for policy. https://ec.europa.eu/knowledge4policy/publication/covid-19-cases-case-fatality-rate-age_en . Accessed 11 May  2020
Bianchetti A, Rozzini R, Guerini F et al (2020) Clinical presentation of COVID19 in dementia patients. J Nutr Health Aging 15:1–3

Auteurs

Salvatore Caratozzolo (S)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Alberto Zucchelli (A)

Unità Geriatria, Dipartimento Scienze Cliniche e Sperimentale, Università degli Studi di Brescia, Brescia, Italy.

Marinella Turla (M)

Neurology Unit, Azienda Socio-Sanitaria Territoriale della Valcamonica, Esine (Brescia), Italy.

Maria Sofia Cotelli (MS)

Neurology Unit, Azienda Socio-Sanitaria Territoriale della Valcamonica, Esine (Brescia), Italy.

Sara Fascendini (S)

Centro di Eccellenza Alzheimer FERB Onlus, Ospedale Briolini di Gazzaniga, Gazzaniga (Bergamo), Italy.

Mara Zanni (M)

Centro di Eccellenza Alzheimer FERB Onlus, Ospedale Briolini di Gazzaniga, Gazzaniga (Bergamo), Italy.

Angelo Bianchetti (A)

Gruppo San Donato - Ospedale Sant'Anna Brescia, Brescia, Italy.
Gruppo di Ricerca Geriatrica, Brescia, Italy.

Matteo Peli Psy (MP)

Gruppo San Donato - Ospedale Sant'Anna Brescia, Brescia, Italy.
Gruppo di Ricerca Geriatrica, Brescia, Italy.

Renzo Rozzini (R)

Unità di Cure Sub Acute, Dipartimento di Geriatria, Fondazione Poliambulanza di Brescia, Brescia, Italy.
Gruppo di Ricerca Geriatrica, Brescia, Italy.

Stefano Boffelli (S)

Unità di Cure Sub Acute, Dipartimento di Geriatria, Fondazione Poliambulanza di Brescia, Brescia, Italy.
Gruppo di Ricerca Geriatrica, Brescia, Italy.

Melania Cappuccio (M)

IPS Cardinal Gusmini, Vertova (Bergamo), Italy.

Federica Gottardi Psy (FG)

IPS Cardinal Gusmini, Vertova (Bergamo), Italy.

Chiara Vecchi Psy (CV)

Coordinamento dei Caffè Alzheimer della Lombardia Orientale, Brescia, Italy.

Daniele Bellandi (D)

Fondazione Sospiro, Cremona, Italy.

Claudia Caminati (C)

Fondazione Sospiro, Cremona, Italy.

Simona Gentile (S)

Fondazione Teresa Camplani - Casa di Cura Ancelle della Carità, Cremona, Italy.

Elena Lucchi Psy (EL)

Fondazione Teresa Camplani - Casa di Cura Ancelle della Carità, Cremona, Italy.

Ignazio Di Fazio (I)

Ospedale Richiedei, Palazzolo (Brescia), Italy.

Marina Zanetti Psy (MZ)

Ospedale Richiedei, Palazzolo (Brescia), Italy.

Giuliana Vezzadini (G)

IRCCS Maugeri, Castel Goffredo (Mantova), Italy.

Chiara Forlani Psy (CF)

IRCCS Maugeri, Castel Goffredo (Mantova), Italy.

Maura Cosseddu Psy (MC)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Rosanna Turrone Psy (RT)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Silvia Pelizzari Psy (SP)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Andrea Scalvini (A)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Marco Di Cesare (M)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

Marta Grigolo Psy (MG)

Gruppo San Donato - Ospedale Sant'Anna Brescia, Brescia, Italy.

Lina Falanga (L)

Unità di Cure Sub Acute, Dipartimento di Geriatria, Fondazione Poliambulanza di Brescia, Brescia, Italy.

Nives Medici (N)

IPS Cardinal Gusmini, Vertova (Bergamo), Italy.

Nives Palamini (N)

IPS Cardinal Gusmini, Vertova (Bergamo), Italy.

Elisa Zanacchi Psy (EZ)

IPS Cardinal Gusmini, Vertova (Bergamo), Italy.

Eleonora Grossi Psy (EG)

Fondazione Teresa Camplani - Casa di Cura Ancelle della Carità, Cremona, Italy.

Giuseppe Bellelli (G)

Dipartimento Medicina e Chirurgia, Clinica Geriatrica, Università Bicocca, Milan, Italy.

Alessandra Marengoni (A)

Unità Geriatria, Dipartimento Scienze Cliniche e Sperimentale, Università degli Studi di Brescia, Brescia, Italy.

Marco Trabucchi (M)

Gruppo di Ricerca Geriatrica, Brescia, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, Center for Neurodegenerative Disorders, Spedali Civili di Brescia, University of Brescia, Brescia, Italy. alessandro.padovani@unibs.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH